Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Analysis and Temporal Evolution of Extubation Parameters for Patients Undergoing Single Stage Circumferential Cervical Spine Surgery.

Fontes RBV, Kochanski RB, Kerolus MG, Garg RK, DelaCruz A, Traynelis VC.

Neurospine. 2020 Feb 2. doi: 10.14245/ns.1938382.191. [Epub ahead of print]

2.

Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey.

Drudge-Coates L, Oh WK, Tombal B, Delacruz A, Tomlinson B, Ripley AV, Mastris K, O'Sullivan JM, Shore ND.

Clin Genitourin Cancer. 2018 Apr;16(2):e411-e419. doi: 10.1016/j.clgc.2017.09.015. Epub 2017 Oct 5.

3.

Factors Predicting Asthma in Children With Acute Bronchiolitis.

Waseem M, Akobo SI, Shaikh F, DelaCruz A, Henriquez W, Leber M.

Pediatr Emerg Care. 2019 Apr;35(4):265-267. doi: 10.1097/PEC.0000000000000983.

PMID:
28257313
4.

Intraspecific variation of a dominant grass and local adaptation in reciprocal garden communities along a US Great Plains' precipitation gradient: implications for grassland restoration with climate change.

Johnson LC, Olsen JT, Tetreault H, DeLaCruz A, Bryant J, Morgan TJ, Knapp M, Bello NM, Baer SG, Maricle BR.

Evol Appl. 2015 Aug;8(7):705-23. doi: 10.1111/eva.12281. Epub 2015 Jul 16.

5.

Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment.

Delacruz A, Arauz G, Curley T, Lindo A, Jensen T.

Clin J Oncol Nurs. 2015 Apr;19(2):E31-5. doi: 10.1188/15.CJON.E31-E35.

PMID:
25840395
6.

Using circulating tumor cells as a prognostic indicator in metastatic castration-resistant prostate cancer.

Delacruz A.

Clin J Oncol Nurs. 2012 Apr;16(2):E44-7. doi: 10.1188/12.CJON.E44-E47. Review.

PMID:
22459536
7.

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.

Iyer G, Morris MJ, Rathkopf D, Slovin SF, Steers M, Larson SM, Schwartz LH, Curley T, DeLaCruz A, Ye Q, Heller G, Egorin MJ, Ivy SP, Rosen N, Scher HI, Solit DB.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1089-97. doi: 10.1007/s00280-011-1789-3. Epub 2011 Nov 29.

8.

Unsuspected pulmonary alveolar proteinosis in a patient with acquired immunodeficiency syndrome: a case report.

Tejwani D, Delacruz AE, Niazi M, Diaz-Fuentes G.

J Med Case Rep. 2011 Feb 1;5:46. doi: 10.1186/1752-1947-5-46.

9.

Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.

Morris MJ, Huang D, Kelly WK, Slovin SF, Stephenson RD, Eicher C, Delacruz A, Curley T, Schwartz LH, Scher HI.

Eur Urol. 2009 Aug;56(2):237-44. doi: 10.1016/j.eururo.2009.03.073. Epub 2009 Apr 3.

10.

Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.

Morris MJ, Pandit-Taskar N, Carrasquillo J, Divgi CR, Slovin S, Kelly WK, Rathkopf D, Gignac GA, Solit D, Schwartz L, Stephenson RD, Hong C, Delacruz A, Curley T, Heller G, Jia X, O'Donoghue J, Larson S, Scher HI.

J Clin Oncol. 2009 May 20;27(15):2436-42. doi: 10.1200/JCO.2008.20.4164. Epub 2009 Apr 13. Erratum in: J Clin Oncol. 2011 Oct 10;29(29):3947-8.

11.

Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer.

Galsky MD, Eisenberger M, Moore-Cooper S, Kelly WK, Slovin SF, DeLaCruz A, Lee Y, Webb IJ, Scher HI.

J Clin Oncol. 2008 May 1;26(13):2147-54. doi: 10.1200/JCO.2007.15.0532. Epub 2008 Mar 24.

PMID:
18362364
12.

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI.

Clin Cancer Res. 2007 Mar 15;13(6):1775-82.

13.

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

Morris MJ, Divgi CR, Pandit-Taskar N, Batraki M, Warren N, Nacca A, Smith-Jones P, Schwartz L, Kelly WK, Slovin S, Solit D, Halpern J, Delacruz A, Curley T, Finn R, O'donoghue JA, Livingston P, Larson S, Scher HI.

Clin Cancer Res. 2005 Oct 15;11(20):7454-61.

14.

Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.

Galsky MD, Small EJ, Oh WK, Chen I, Smith DC, Colevas AD, Martone L, Curley T, Delacruz A, Scher HI, Kelly WK.

J Clin Oncol. 2005 Mar 1;23(7):1439-46.

PMID:
15735119
15.

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.

Morris MJ, Smaletz O, Solit D, Kelly WK, Slovin S, Flombaum C, Curley T, Delacruz A, Schwartz L, Fleisher M, Zhu A, Diani M, Fallon M, Scher HI.

Cancer. 2004 May 1;100(9):1868-75.

16.

Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration.

Smaletz O, Galsky M, Scher HI, DeLaCruz A, Slovin SF, Morris MJ, Solit DB, Davar U, Schwartz L, Kelly WK.

Ann Oncol. 2003 Oct;14(10):1518-24.

17.

Working with neglecting families.

Hall M, DeLaCruz A, Russell P.

Child Today. 1982 Mar-Apr;11(2):6-9, 36. No abstract available.

PMID:
7083956
18.

BACTERIA RESPONSIBLE FOR MUCILAGE-LAYER DECOMPOSITION IN KONA COFFEE CHERRIES.

FRANK HA, LUM NA, DELACRUZ AS.

Appl Microbiol. 1965 Mar;13:201-7.

19.

A STUDY OF THE SERUM PROTEINS OF YOUNG AND OLD HORSESHOE CRABS (LIMULUS POLYPHEMUS L.).

DELACRUZ AA, CHAET AB.

Embryologia (Nagoya). 1965 Feb;9:337-44. No abstract available.

PMID:
14346506

Supplemental Content

Loading ...
Support Center